GPT-5
GPT-5 is a multimodal large language model developed by OpenAI and the fifth in its series of generative pre-trained transformer (GPT) foundation models. Preceded in the series by GPT-4, it was launched on August 7, 2025. It is publicly accessible to users of the chatbot products ChatGPT and Microso
GPT-5, OpenAI's multimodal flagship launched August 7, 2025, deploys Mixture of Experts and Chain-of-Thought Prompting, but its edge is eroding fast. Anthropic's Claude Opus 4.7 just posted 80.1% on SWE-Bench with 1M context, while AllenAI's MolmoAct2 beat GPT-5 on robotics with a 720-hour bimanual dataset. Both models explicitly list GPT-5 as a competitor. Meanwhile, OpenAI shipped GPT-5.5 in April 2026 targeting smarter agents and deeper tool use, suggesting an accelerated cadence driven by competitive pressure. A recent study also flagged GPT-5's central tendency bias in clinical scoring, a reliability concern for high-stakes deployments. The model now powers ChatGPT and Microsoft's HORIZON product, widening its distribution surface but also its liability.
- ·GPT-5 uses Sparse MoE and Chain-of-Thought, launched August 2025
- ·Competes directly with Claude Opus 4.7 (80.1% SWE-Bench) and MolmoAct2 (robotics leader)
- ·GPT-5.5 shipped April 2026, indicating accelerated iteration cycle
- ·Central tendency bias in clinical scoring flagged in recent study
- ·Distributed via ChatGPT and Microsoft HORIZON product
Signal Radar
Five-axis snapshot of this entity's footprint
Mentions × Lab Attention
Weekly mentions (solid) and average article relevance (dotted)
Timeline
3- Research MilestoneMay 11, 2026
Study reveals GPT-5 exhibits central tendency bias in clinical scoring, compressing predictions toward scale midpoint.
View source- mae zero shot:
- 0.67
- within 1 accuracy:
- 92%
- Research MilestoneMar 6, 2026
Evaluation study published on arXiv assessing its clinical reasoning capabilities
View source - Product LaunchMay 31, 2025
Reportedly became available according to user social media post
View source
Relationships
9Developed
Deploys
Uses
Frequently appears with
10Entities that show up in the same articles — shared coverage, not a stated relationship.
Recent Articles
2MLLM Raters Show Central Tendency Bias in Clinical Scoring
-Study finds GPT-5 and other MLLMs show central tendency bias in clinical scoring, compressing predictions toward scale midpoint despite prompt modific
70 relevanceAnthropic Ships Claude Opus 4.7: 80.1 SWE-Bench, 1M Context
~Anthropic released Claude Opus 4.7 on April 16, 2026, scoring 80.1 on SWE-Bench Verified, a slight regression from Opus 4.6's 80.3. The release priori
100 relevance
Predictions
No predictions linked to this entity.
AI Discoveries
1- observationactiveJun 5, 2026
Lifecycle: GPT-5
GPT-5 is in 'declining' phase (0 mentions/3d, 0/14d, 29 total)
90% confidence
Sentiment History
| Week | Avg Sentiment | Mentions |
|---|---|---|
| 2026-W17 | 0.20 | 5 |
| 2026-W19 | -0.30 | 1 |
| 2026-W20 | -0.60 | 1 |
| 2026-W21 | -0.15 | 2 |